Focal epilepsy affects over 30 million patients worldwide and is commonly caused by brain lesions, such as stroke.
Cytisinicline could offer adult cigarette smokers a potential new treatment option
The first large-scale U.S. clinical trial of cytisinicline, led by a Massachusetts General Hospital (MGH) investigator, found the smoking cessation medication to be effective and